Cantourage Group SE (ETR:HIGH)

Market Cap	64.59M +41.9%
Revenue (ttm)	3.91M +78.0%
Net Income	126.46K +59.5%
EPS	n/a
Shares Out	12.47M
PE Ratio	510.80
Forward PE	53.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,377
Open	5.12
Previous Close	5.20
Day's Range	4.91 - 5.18
52-Week Range	2.32 - 6.86
Beta	-0.00
Analysts	Strong Buy
Price Target	10.50 (+102.7%)
Earnings Date	Nov 10, 2026

About Cantourage Group SE

Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 11
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: HIGH

Financial Performance

In 2025, Cantourage Group SE's revenue was 3.91 million, an increase of 77.97% compared to the previous year's 2.20 million. Earnings were 126,458, an increase of 59.48%.

Analyst Summary

According to 3 analysts, the average rating for HIGH stock is "Strong Buy." The 12-month stock price target is €10.50, which is an increase of 102.70% from the latest price.

Price Target

€10.50

(102.70% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 6, 2026

Data Sources Report a data error